| Mr George D Mclean, PT | |
|
200 Front Street, Suite D, Vestal, NY 13850 | |
| (607) 754-1776 | |
| (607) 748-5465 |
| Full Name | Mr George D Mclean |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 200 Front Street, Vestal, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144257122 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 0064311 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr George D Mclean, PT 200 Front St, Suite D, Vestal, NY 13850-1559 Ph: (607) 754-1776 | Mr George D Mclean, PT 200 Front Street, Suite D, Vestal, NY 13850 Ph: (607) 754-1776 |
News Archive
Evonik is the first company in the world to launch a 3D-printable PEEK (polyether ether ketone) filament as an implant-grade material for medical applications.
Genetically engineered mouse models are often used by scientists to study how the addition, deletion or mutation of genes affects the development of disease and effects of drugs.
New research from University of California, Davis, suggests that parents should delay introducing their children to any screen media, as well as limit preschool-age children's use of mobile devices, including smartphones and tablets.
These proteins are required for melanocyte stem cell self-maintenance and, as such, correct pigmentation throughout the mice's life span. Without these two proteins, the mice's fur turns white. Their research is published in the review 'Cell Report' and paves the way for serious possibilities in terms of stopping the formation of melanomas, tumours that originate from melanocyte cells.
ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.
› Verified 5 days ago
Thomas L Komor, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4433 Vestal Pkwy E, Vestal, NY 13850 Phone: 607-762-2176 | |
John Todd Mansfield, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 Front St, Suite D, Vestal, NY 13850 Phone: 607-754-1776 Fax: 607-748-5465 | |
Mrs. Brittany Mallonga, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1105 Hillside Dr, Vestal, NY 13850 Phone: 607-759-0968 | |
Dr. Katherine S Barnhart, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3101 Shippers Rd Ste 108, Vestal, NY 13850 Phone: 607-251-2200 | |
David Martin, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1500 Vestal Pkwy E, Vestal, NY 13850 Phone: 607-240-9120 | |
Anjana Ashok, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1715 Castle Gardens Rd, Suite 105, Vestal, NY 13850 Phone: 607-484-5079 Fax: 631-467-0928 | |
Mr. Matthew John Mcmahon, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 200 Front St, Suite D, Vestal, NY 13850 Phone: 607-754-1776 Fax: 607-748-5465 |